Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Tural, D, Serdengecti, S, Demirelli, F, Öztürk, T, İlvan, S, Turna, H, Özgüroglu, M, Büyükünal, E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056067/
https://www.ncbi.nlm.nih.gov/pubmed/24919019
http://dx.doi.org/10.1038/bjc.2014.314
_version_ 1782320776645443584
author Tural, D
Serdengecti, S
Demirelli, F
Öztürk, T
İlvan, S
Turna, H
Özgüroglu, M
Büyükünal, E
author_facet Tural, D
Serdengecti, S
Demirelli, F
Öztürk, T
İlvan, S
Turna, H
Özgüroglu, M
Büyükünal, E
author_sort Tural, D
collection PubMed
description
format Online
Article
Text
id pubmed-4056067
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-40560672015-04-15 Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies Tural, D Serdengecti, S Demirelli, F Öztürk, T İlvan, S Turna, H Özgüroglu, M Büyükünal, E Br J Cancer Retraction Nature Publishing Group 2014-06-10 2014-06-10 /pmc/articles/PMC4056067/ /pubmed/24919019 http://dx.doi.org/10.1038/bjc.2014.314 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Retraction
Tural, D
Serdengecti, S
Demirelli, F
Öztürk, T
İlvan, S
Turna, H
Özgüroglu, M
Büyükünal, E
Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
title Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
title_full Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
title_fullStr Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
title_full_unstemmed Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
title_short Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
title_sort clinical significance of p95her2 overexpression, pten loss and pi3k expression in p185her2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056067/
https://www.ncbi.nlm.nih.gov/pubmed/24919019
http://dx.doi.org/10.1038/bjc.2014.314
work_keys_str_mv AT turald clinicalsignificanceofp95her2overexpressionptenlossandpi3kexpressioninp185her2positivemetastaticbreastcancerpatientstreatedwithtrastuzumabbasedtherapies
AT serdengectis clinicalsignificanceofp95her2overexpressionptenlossandpi3kexpressioninp185her2positivemetastaticbreastcancerpatientstreatedwithtrastuzumabbasedtherapies
AT demirellif clinicalsignificanceofp95her2overexpressionptenlossandpi3kexpressioninp185her2positivemetastaticbreastcancerpatientstreatedwithtrastuzumabbasedtherapies
AT ozturkt clinicalsignificanceofp95her2overexpressionptenlossandpi3kexpressioninp185her2positivemetastaticbreastcancerpatientstreatedwithtrastuzumabbasedtherapies
AT ilvans clinicalsignificanceofp95her2overexpressionptenlossandpi3kexpressioninp185her2positivemetastaticbreastcancerpatientstreatedwithtrastuzumabbasedtherapies
AT turnah clinicalsignificanceofp95her2overexpressionptenlossandpi3kexpressioninp185her2positivemetastaticbreastcancerpatientstreatedwithtrastuzumabbasedtherapies
AT ozguroglum clinicalsignificanceofp95her2overexpressionptenlossandpi3kexpressioninp185her2positivemetastaticbreastcancerpatientstreatedwithtrastuzumabbasedtherapies
AT buyukunale clinicalsignificanceofp95her2overexpressionptenlossandpi3kexpressioninp185her2positivemetastaticbreastcancerpatientstreatedwithtrastuzumabbasedtherapies

Ejemplares similares